Rheacell Gmbh & Cokg Is A Biopharmaceutical Company Based In Heidelberggermanyspecializing In Stem Cell Therapiesfounded In 2003 By Drchristoph Ganssrheacell Focuses On Abcb5Mesenchymal Stromal Cellswhich Are Known For Their Anti Inflammatory And Immune Modulatory Propertiesthe Company Has Transitioned From Being The First Tissue Bank For Skin Stem Cells To A Key Player In The Biotechnology Sector Rheacell Is Committed To Developing Innovative Treatments For Inflammation Driven Diseasesparticularly Rare Pediatric And Dermatological Conditionsthe Company Is Actively Involved In Late Stage Clinical Trialsincluding A Pivotal Phase Iii Trial For Epidermolysis Bullosa In Both The Eu And Uswith A Gmp Certified Manufacturing Facilityrheacell Ensures High Quality Production Of Its Therapies And Holds Licenses For Products Like Amesanar And Ebesanarthe Company Collaborates With Leading Experts And Institutions To Advance Its Research And Therapeutic Offerings In Regenerative Medicine
